VSee Health, Inc. Employee Benefits and Share-based Compensation
VSee Health, Inc. (VSEE) reported Employee Benefits and Share-based Compensation of $649.50 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2026-08-14
- VSee Health, Inc. employee benefits and share-based compensation for the quarter ending 2026-06-30 was $649.50K, a 45.60% increase year-over-year.
- VSee Health, Inc. employee benefits and share-based compensation for the quarter ending 2026-03-31 was $1.73M, a 4.40% increase year-over-year.
- VSee Health, Inc. employee benefits and share-based compensation for the quarter ending 2025-12-31 was $2.36M, a 33.26% increase year-over-year.
- VSee Health, Inc. employee benefits and share-based compensation for the quarter ending 2025-09-30 was $1.21M, a 29.86% decline year-over-year.
- VSee Health, Inc. employee benefits and share-based compensation for fiscal 2025 was $6.90M, a 30.06% increase from fiscal 2024.
- VSee Health, Inc. employee benefits and share-based compensation for fiscal 2024 was $5.31M, a 20.14% increase from fiscal 2023.
- VSee Health, Inc. employee benefits and share-based compensation for fiscal 2023 was $4.42M.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 3 month as first filed | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 6 month as first filed | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 9 month as first filed | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $649.50K 10-Q · filed 2026-08-14 | $898.52K 10-Q · filed 2026-08-14 | $4.74M derived: sum of 3 quarters · filed 2026-08-14 | $5.95M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | $1.73M 10-Q · filed 2026-05-15 | $4.09M derived: sum of 2 quarters · filed 2026-05-15 | $5.30M derived: sum of 3 quarters · filed 2026-05-15 | $5.75M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $3.57M derived: sum of 2 quarters · filed 2026-03-31 | $4.02M derived: sum of 3 quarters · filed 2026-08-14 | $6.90M 10-K · filed 2026-03-31 | |||
| 2025-09-30 | $1.21M 10-Q · filed 2025-11-14 | $1.66M derived: sum of 2 quarters · filed 2026-08-14 | $4.54M 10-Q · filed 2025-11-14 | $5.09M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | $446.10K 10-Q · filed 2026-08-14 | $1.67M 10-Q · filed 2025-10-15 | $941.04K 10-Q · filed 2026-08-14 | $3.33M 10-Q · filed 2025-10-15 | $3.87M derived: sum of 3 quarters · filed 2026-08-14 | $5.61M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $1.66M 10-Q · filed 2026-05-15 | $3.43M derived: sum of 2 quarters · filed 2026-05-15 | $5.16M derived: sum of 3 quarters · filed 2026-05-15 | $6.07M derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $3.50M derived: sum of 2 quarters · filed 2026-03-31 | $4.41M derived: sum of 3 quarters · filed 2026-03-31 | $5.31M 10-K · filed 2026-03-31 | |||
| 2024-09-30 | $1.73M 10-Q · filed 2025-11-14 | $1.68M 10-Q · filed 2024-11-14 | $2.64M derived: sum of 2 quarters · filed 2025-11-20 | $3.54M 10-Q · filed 2025-11-14 | $3.49M 10-Q · filed 2024-11-14 | $4.52M derived: sum of 4 quarters · filed 2025-11-20 | |
| 2024-06-30 | $912.74K 10-Q/A · filed 2025-11-20 | $918.41K 10-Q · filed 2024-09-23 | $1.81M 10-Q/A · filed 2025-11-20 | $1.81M 10-Q · filed 2024-09-23 | $2.79M derived: sum of 3 quarters · filed 2025-11-20 | $3.80M derived: sum of 4 quarters · filed 2025-11-20 | |
| 2024-03-31 | $893.58K 10-Q · filed 2025-10-15 | $1.88M derived: sum of 2 quarters · filed 2025-10-15 | $2.89M derived: sum of 3 quarters · filed 2025-10-15 | $3.98M derived: sum of 4 quarters · filed 2025-10-15 | |||
| 2023-12-31 | $983.37K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-29 | $2.00M derived: sum of 2 quarters · filed 2025-08-29 | $3.08M derived: sum of 3 quarters · filed 2025-08-29 | $4.42M 10-K/A · filed 2025-08-29 | |||
| 2023-09-30 | $1.01M 10-Q · filed 2024-11-14 | $2.10M derived: sum of 2 quarters · filed 2024-11-14 | $3.43M 10-Q · filed 2024-11-14 | ||||
| 2023-06-30 | $1.08M 10-Q · filed 2024-09-23 | $2.42M 10-Q · filed 2024-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |